Role of Intravitreal Antivascular Endothelial Growth Factor Injections for Choroidal Neovascularization due to Choroidal Osteoma

We treated 26 eyes of 25 young patients having a mean age of 30 years with intravitreal vascular endothelial growth factor (VEGF) inhibitor for choroidal new vessel (CNV) formation overlying choroidal osteoma over a mean follow-up of 26 months. Mean number of injections was 2.4 at 6 months, 3.2 at 1...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Mansour, Ahmad M., Arevalo, J. Fernando, Al Kahtani, Eman, Zegarra, Hernando, Abboud, Emad, Anand, Rajiv, Ahmadieh, Hamid, Sisk, Robert A., Mirza, Salman, Tuncer, Samuray, Navea Tejerina, Amparo, Mataix, Jorge, Ascaso, Francisco J., Pulido, Jose S., Guthoff, Rainer, Goebel, Winfried, Roh, Young Jung, Banker, Alay S., Gentile, Ronald C., Martinez, Isabel Alonso, Morris, Rodney, Panday, Neeraj, Min, Park Jung, Mercé, Emilie, Lai, Timothy Y. Y., Massoud, Vicky, Ghazi, Nicola G.
Formato: Artigo
Lenguaje:Inglês
Publicado: Hindawi Publishing Corporation 2014
Materias:
Clinical Study
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4132478/
https://ncbi.nlm.nih.gov/pubmed/25147732
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2014/210458
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares